Yokoyama, S., Perera, P., Waldmann, T. A., Hiroi, T., & Perera, L. P. (2012). Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease.
Citação norma ChicagoYokoyama, Seiji, Pin-Yu Perera, Thomas A. Waldmann, Takachika Hiroi, and Liyanage P. Perera. Tofacitinib, a Janus Kinase Inhibitor Demonstrates Efficacy in an IL-15 Transgenic Mouse Model That Recapitulates Pathologic Manifestations of Celiac Disease. 2012.
Citação norma MLAYokoyama, Seiji, et al. Tofacitinib, a Janus Kinase Inhibitor Demonstrates Efficacy in an IL-15 Transgenic Mouse Model That Recapitulates Pathologic Manifestations of Celiac Disease. 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.